Therapeutic Vaccines Market was valued at USD 6.1 Billion in 2022 and is projected to reach USD 15.4 Billion by 2030, growing at a CAGR of 12.1% from 2024 to 2030.
The therapeutic vaccines market was valued at approximately USD 2.1 billion in 2022, with projections indicating a robust compound annual growth rate (CAGR) of 11.5% from 2023 to 2030. This growth is driven by the increasing prevalence of chronic diseases and the rising demand for advanced treatment options. The market's expansion is further supported by continuous advancements in vaccine technologies and the growing focus on personalized medicine. Key therapeutic areas include oncology, infectious diseases, and autoimmune disorders, where vaccines are evolving from preventive to therapeutic solutions, offering significant potential for market growth.
Opportunities in the therapeutic vaccines market are driven by innovations in genetic engineering, peptide vaccines, and novel adjuvants that enhance the efficacy of existing therapies. Emerging markets, particularly in Asia-Pacific and Latin America, are expected to witness substantial growth due to increasing healthcare investments and a rising patient population. The development of personalized therapeutic vaccines tailored to individual genetic profiles is also expected to open new avenues for market expansion. Additionally, strategic collaborations and partnerships among biotech firms and research institutions are anticipated to accelerate the development and commercialization of advanced therapeutic vaccines.
Get an In-Depth Research Analysis of the Global Therapeutic Vaccines Market Size And Forecast [2025-2032]
Vaccinogen
CIMAB S.A.
Corixa
Galena Biopharma
Bavarian Nordic
GlaxoSmithKline plc.
Northwest Biotherapeutics
Novartis AG
Argos Therapeutics
Sanpower Group Co. Ltd.
Pfizer Inc.
Aimmune Therapeutics Inc.
AVAX
Agenus Inc.
Immune Response BioPharma Inc.
Inovio Pharmaceuticals Inc.
Dendreon
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Therapeutic Vaccines Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Therapeutic Vaccines Market
Allogeneic Vaccine
Autologous Vaccine
Based on Types the Market is categorized into Below types that held the largest Therapeutic Vaccines market share In 2023.
Autoimmune Disease Vaccines
Neurological Disease Vaccines
Cancer Vaccines
Infectious Disease Vaccines
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Therapeutic Vaccines Market Research Analysis
1. Introduction of the Global Therapeutic Vaccines Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Therapeutic Vaccines Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Therapeutic Vaccines Market, By Type
6. Global Therapeutic Vaccines Market, By Application
7. Global Therapeutic Vaccines Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Therapeutic Vaccines Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/